FDA Approves Veklury (remdesivir) to Treat COVID-19 in People With Mild to Severe Hepatic Impairment With no Dose Adjustment

Press/Media

Period	30 Aug 2023

Media coverage

Title	FDA Approves Veklury (remdesivir) to Treat COVID-19 in People With Mild to Severe Hepatic Impairment With no Dose Adjustment
Media name/outlet	Drugs.com
Country/Territory	United States
Date	30/08/23
URL	https://www.drugs.com/newdrugs/fda-approves-veklury-remdesivir-covid-19-mild-severe-hepatic-impairment-no-adjustment-6085.html
Persons	Douglas Dieterich